NCT01014728

Brief Summary

The purpose of this study is to compare the blood loss during sinus surgery looking at two different types of anesthesia: either intravenous anesthesia with propofol or inhalational anesthesia with sevoflurane.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

November 13, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 17, 2009

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

January 9, 2014

Completed
Last Updated

February 14, 2014

Status Verified

January 1, 2014

Enrollment Period

2.3 years

First QC Date

November 13, 2009

Results QC Date

November 20, 2013

Last Update Submit

January 21, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Estimated Blood Loss

    Estimated blood loss in milliliters per hour is calculated by subtracting the volume of total irrigation used during the case from the total amount of fluid in the suction canister at the end of surgery and dividing by surgical time in hours.

    from the start of surgery to the end of surgery, up to 6 hours

Secondary Outcomes (2)

  • Anesthesiologist Numeric Rating Scale (ANRS)

    at the end of surgery (up to 6 hours)

  • Surgeon's Numeric Rating Scale (SNRS)

    at the end of surgery (up to 6 hours)

Study Arms (2)

Intravenous anesthesia

ACTIVE COMPARATOR

Intravenous anesthesia with propofol for endoscopic sinus surgery

Drug: propofol

Inhalation anesthesia

ACTIVE COMPARATOR

Inhalation anesthesia with sevoflurane for endoscopic sinus surgery

Drug: sevoflurane

Interventions

100-200mcg/kg/min by infusion

Intravenous anesthesia

1-3% of sevoflurane (expired)

Inhalation anesthesia

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • male or female patients who are 18 years of age or older,
  • ASA grade 1 (normal otherwise healthy patient),
  • ASA grade 2 (patient with mild systemic disease),
  • patients who have chronic sinusitis with or without nasal polyps.

You may not qualify if:

  • pregnancy,
  • abnormal coagulation panel
  • preoperative use of NSAIDS or ASA medications within 7 days,
  • end-stage renal disease,
  • allergy to any of the used medications,
  • maximal body mass index over 35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Chicago

Chicago, Illinois, 60637, United States

Location

MeSH Terms

Conditions

Hemorrhage

Interventions

PropofolSevoflurane

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsMethyl EthersEthersHydrocarbons, FluorinatedHydrocarbons, Halogenated

Results Point of Contact

Title
Dr. Robert Naclerio
Organization
University of Chicago

Study Officials

  • Robert M Naclerio, MD

    University of Chicago

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 13, 2009

First Posted

November 17, 2009

Study Start

November 1, 2009

Primary Completion

March 1, 2012

Study Completion

June 1, 2012

Last Updated

February 14, 2014

Results First Posted

January 9, 2014

Record last verified: 2014-01

Locations